HEADER IMMUNE SYSTEM 28-SEP-23 8UDR TITLE STRUCTURE OF THE P1B7 ANTIBODY BOUND TO THE SOTORASIB-MODIFIED KRAS TITLE 2 G12C PEPTIDE PRESENTED BY THE A*03:01 MHC I COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: GTPASE KRAS, N-TERMINALLY PROCESSED; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE: P1B7 HEAVY CHAIN; COMPND 15 CHAIN: D; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 5; COMPND 18 MOLECULE: P1B7 LIGHT CHAIN; COMPND 19 CHAIN: E; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606; SOURCE 20 MOL_ID: 4; SOURCE 21 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 25 EXPRESSION_SYSTEM_CELL_LINE: HEK293T; SOURCE 26 MOL_ID: 5; SOURCE 27 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 28 ORGANISM_TAXID: 9606; SOURCE 29 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 30 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 31 EXPRESSION_SYSTEM_CELL_LINE: HEK293T KEYWDS ANTIBODY, MHC, HAPTENATED PEPTIDE, PEPTIDE BINDING PROTEIN, IMMUNE KEYWDS 2 SYSTEM EXPDTA ELECTRON MICROSCOPY AUTHOR L.M.CHAN,P.J.ROWEDER,C.S.CRAIK,K.A.VERBA REVDAT 1 16-OCT-24 8UDR 0 JRNL AUTH A.PANDEY,P.J.ROHWEDER,L.M.CHAN,C.ONGPIPATTANAKUL,D.CHUNG, JRNL AUTH 2 B.PAOLELLA,F.M.QUIMBY,N.NGUYEN,K.A.VERBA,M.J.EVANS,C.S.CRAIK JRNL TITL THERAPEUTIC TARGETING AND STRUCTURAL CHARACTERIZATION OF A JRNL TITL 2 SOTORASIB-HAPTENATED KRAS G12C MHC I COMPLEX JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, SERIALEM, CRYOSPARC, REMARK 3 CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.100 REMARK 3 NUMBER OF PARTICLES : 286405 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8UDR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1000277803. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : P1B7 ANTIBODY:V7-SOTORASIB REMARK 245 A*03:01 MHC I COMPLEX REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.08 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 3795 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 7000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 20000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4580.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 105000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR D 161 REMARK 465 SER D 162 REMARK 465 GLY D 163 REMARK 465 GLY D 164 REMARK 465 THR D 165 REMARK 465 PRO D 243 REMARK 465 LYS D 244 REMARK 465 SER D 245 REMARK 465 CYS D 246 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN A 127 HG1 THR A 134 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 6 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 44 NE - CZ - NH2 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG A 157 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 181 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG D 75 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG D 89 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG E 76 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -127.98 51.44 REMARK 500 ASP A 220 17.20 53.52 REMARK 500 ARG D 75 -60.35 -124.64 REMARK 500 LYS E 138 56.41 39.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-42151 RELATED DB: EMDB REMARK 900 STRUCTURE OF THE P1B7 ANTIBODY BOUND TO THE SOTORASIB-MODIFIED KRAS REMARK 900 G12C PEPTIDE PRESENTED BY THE A*03:01 MHC I COMPLEX DBREF 8UDR A 1 275 UNP P04439 HLAA_HUMAN 25 299 DBREF 8UDR B 21 119 UNP P61769 B2MG_HUMAN 21 119 DBREF 8UDR C 7 16 UNP P01116 RASK_HUMAN 7 16 DBREF 8UDR D 21 246 PDB 8UDR 8UDR 21 246 DBREF 8UDR E 23 238 PDB 8UDR 8UDR 23 238 SEQADV 8UDR CYS C 12 UNP P01116 GLY 12 VARIANT SEQRES 1 A 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLN GLU THR ARG SEQRES 6 A 275 ASN VAL LYS ALA GLN SER GLN THR ASP ARG VAL ASP LEU SEQRES 7 A 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 275 SER HIS THR ILE GLN ILE MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 275 SER ASP GLY ARG PHE LEU ARG GLY TYR ARG GLN ASP ALA SEQRES 10 A 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP LEU SEQRES 11 A 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN ILE THR SEQRES 12 A 275 LYS ARG LYS TRP GLU ALA ALA HIS GLU ALA GLU GLN LEU SEQRES 13 A 275 ARG ALA TYR LEU ASP GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 275 ASP PRO PRO LYS THR HIS MET THR HIS HIS PRO ILE SER SEQRES 16 A 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY PHE SEQRES 17 A 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 275 VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 275 TRP GLU SEQRES 1 B 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 B 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 B 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 B 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 B 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 B 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 B 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 10 VAL VAL VAL GLY ALA CYS GLY VAL GLY LYS SEQRES 1 D 226 VAL GLN LEU GLN GLN SER GLY PRO GLY LEU VAL LYS PRO SEQRES 2 D 226 SER GLN THR LEU SER LEU THR CYS ALA ILE SER GLY ASP SEQRES 3 D 226 SER VAL SER SER ASN SER VAL ALA TRP ASN TRP ILE ARG SEQRES 4 D 226 GLN SER PRO SER ARG GLY LEU GLU TRP LEU GLY ARG THR SEQRES 5 D 226 TYR TYR ARG SER LYS TRP TYR SER ASP TYR ALA VAL SER SEQRES 6 D 226 VAL LYS SER ARG ILE THR ILE ASN PRO ASP THR SER LYS SEQRES 7 D 226 ASN GLN PHE SER LEU GLN LEU THR SER MET THR PRO GLU SEQRES 8 D 226 ASP THR ALA VAL TYR TYR CYS ALA ARG GLU GLY VAL THR SEQRES 9 D 226 MET GLY PRO GLY ALA PHE ASP ILE TRP GLY GLN GLY THR SEQRES 10 D 226 MET VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER SEQRES 11 D 226 VAL PHE PRO LEU ALA PRO SER SER LYS SER THR SER GLY SEQRES 12 D 226 GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE SEQRES 13 D 226 PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU SEQRES 14 D 226 THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SEQRES 15 D 226 SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SEQRES 16 D 226 SER SER SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL SEQRES 17 D 226 ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL SEQRES 18 D 226 GLU PRO LYS SER CYS SEQRES 1 E 213 ALA LEU THR GLN PRO PRO SER VAL SER GLY SER PRO GLY SEQRES 2 E 213 GLN SER VAL THR ILE SER CYS THR GLY SER SER SER ASP SEQRES 3 E 213 VAL GLY HIS TYR ASN ARG VAL SER TRP TYR GLN GLN SER SEQRES 4 E 213 PRO GLY THR ALA PRO LYS LEU MET ILE TYR ASP VAL SER SEQRES 5 E 213 ASN ARG PRO SER GLY ALA PHE SER ARG PHE SER GLY SER SEQRES 6 E 213 ARG SER GLY ASN THR ALA SER LEU THR ILE SER GLY LEU SEQRES 7 E 213 GLN PRO GLU ASP GLU ALA ASP TYR TYR CYS SER SER HIS SEQRES 8 E 213 ARG THR GLY TYR THR VAL GLU VAL PHE GLY THR GLY THR SEQRES 9 E 213 LYS VAL THR VAL LEU GLY GLN PRO LYS ALA ALA PRO SER SEQRES 10 E 213 VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN ALA SEQRES 11 E 213 ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE TYR SEQRES 12 E 213 PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SER SER SEQRES 13 E 213 PRO VAL LYS ALA GLY VAL GLU THR THR THR PRO SER LYS SEQRES 14 E 213 GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SER SEQRES 15 E 213 LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER TYR SER SEQRES 16 E 213 CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS THR SEQRES 17 E 213 VAL ALA PRO THR GLU HET MOV D 301 41 HETNAM MOV AMG 510 (BOUND FORM) HETSYN MOV 6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-4-[(2S)-2-METHYL- HETSYN 2 MOV 4-PROPANOYLPIPERAZIN-1-YL]-1-[4-METHYL-2-(PROPAN-2- HETSYN 3 MOV YL)PYRIDIN-3-YL]PYRIDO[2,3-D]PYRIMIDIN-2(1H)-ONE FORMUL 6 MOV C30 H32 F2 N6 O3 HELIX 1 AA1 GLY A 56 TYR A 85 1 30 HELIX 2 AA2 ALA A 139 ALA A 150 1 12 HELIX 3 AA3 HIS A 151 ASP A 161 1 11 HELIX 4 AA4 GLY A 162 GLY A 175 1 14 HELIX 5 AA5 GLY A 175 GLN A 180 1 6 HELIX 6 AA6 THR A 225 THR A 228 5 4 HELIX 7 AA7 THR D 109 THR D 113 5 5 HELIX 8 AA8 SER D 186 ALA D 188 5 3 HELIX 9 AA9 PRO D 215 GLY D 220 1 6 HELIX 10 AB1 LYS D 231 ASN D 234 5 4 HELIX 11 AB2 SER E 78 SER E 82 5 5 HELIX 12 AB3 GLN E 101 GLU E 105 5 5 HELIX 13 AB4 SER E 149 GLN E 154 1 6 HELIX 14 AB5 THR E 209 HIS E 216 1 8 SHEET 1 AA1 8 GLU A 46 PRO A 47 0 SHEET 2 AA1 8 THR A 31 ASP A 37 -1 N ARG A 35 O GLU A 46 SHEET 3 AA1 8 ARG A 21 VAL A 28 -1 N VAL A 28 O THR A 31 SHEET 4 AA1 8 HIS A 3 VAL A 12 -1 N PHE A 8 O VAL A 25 SHEET 5 AA1 8 THR A 94 VAL A 103 -1 O VAL A 103 N HIS A 3 SHEET 6 AA1 8 PHE A 109 TYR A 118 -1 O ARG A 111 N ASP A 102 SHEET 7 AA1 8 LYS A 121 LEU A 126 -1 O ILE A 124 N ASP A 116 SHEET 8 AA1 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AA2 4 HIS A 188 PRO A 193 0 SHEET 2 AA2 4 GLU A 198 PHE A 208 -1 O TRP A 204 N HIS A 188 SHEET 3 AA2 4 PHE A 241 PRO A 250 -1 O VAL A 249 N ALA A 199 SHEET 4 AA2 4 GLU A 229 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 AA3 4 HIS A 188 PRO A 193 0 SHEET 2 AA3 4 GLU A 198 PHE A 208 -1 O TRP A 204 N HIS A 188 SHEET 3 AA3 4 PHE A 241 PRO A 250 -1 O VAL A 249 N ALA A 199 SHEET 4 AA3 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 AA4 4 GLU A 222 ASP A 223 0 SHEET 2 AA4 4 THR A 214 ARG A 219 -1 N ARG A 219 O GLU A 222 SHEET 3 AA4 4 TYR A 257 GLN A 262 -1 O HIS A 260 N THR A 216 SHEET 4 AA4 4 LEU A 270 LEU A 272 -1 O LEU A 272 N CYS A 259 SHEET 1 AA5 4 LYS B 26 SER B 31 0 SHEET 2 AA5 4 ASN B 41 PHE B 50 -1 O ASN B 44 N TYR B 30 SHEET 3 AA5 4 PHE B 82 PHE B 90 -1 O THR B 88 N LEU B 43 SHEET 4 AA5 4 GLU B 70 HIS B 71 -1 N GLU B 70 O TYR B 87 SHEET 1 AA6 4 LYS B 26 SER B 31 0 SHEET 2 AA6 4 ASN B 41 PHE B 50 -1 O ASN B 44 N TYR B 30 SHEET 3 AA6 4 PHE B 82 PHE B 90 -1 O THR B 88 N LEU B 43 SHEET 4 AA6 4 SER B 75 PHE B 76 -1 N SER B 75 O TYR B 83 SHEET 1 AA7 4 GLU B 64 ARG B 65 0 SHEET 2 AA7 4 ILE B 55 LYS B 61 -1 N LYS B 61 O GLU B 64 SHEET 3 AA7 4 TYR B 98 HIS B 104 -1 O ALA B 99 N LEU B 60 SHEET 4 AA7 4 LYS B 111 LYS B 114 -1 O LYS B 111 N VAL B 102 SHEET 1 AA8 4 GLN D 22 SER D 26 0 SHEET 2 AA8 4 LEU D 37 SER D 44 -1 O THR D 40 N SER D 26 SHEET 3 AA8 4 GLN D 100 LEU D 105 -1 O PHE D 101 N CYS D 41 SHEET 4 AA8 4 ILE D 90 ASP D 95 -1 N ASP D 95 O GLN D 100 SHEET 1 AA9 6 LEU D 30 VAL D 31 0 SHEET 2 AA9 6 THR D 137 VAL D 141 1 O THR D 140 N VAL D 31 SHEET 3 AA9 6 ALA D 114 GLY D 122 -1 N TYR D 116 O THR D 137 SHEET 4 AA9 6 VAL D 53 SER D 61 -1 N ILE D 58 O TYR D 117 SHEET 5 AA9 6 GLY D 65 TYR D 74 -1 O GLU D 67 N ARG D 59 SHEET 6 AA9 6 TRP D 78 TYR D 82 -1 O TYR D 79 N TYR D 73 SHEET 1 AB1 4 LEU D 30 VAL D 31 0 SHEET 2 AB1 4 THR D 137 VAL D 141 1 O THR D 140 N VAL D 31 SHEET 3 AB1 4 ALA D 114 GLY D 122 -1 N TYR D 116 O THR D 137 SHEET 4 AB1 4 ILE D 132 TRP D 133 -1 O ILE D 132 N ARG D 120 SHEET 1 AB2 4 SER D 150 LEU D 154 0 SHEET 2 AB2 4 ALA D 167 TYR D 175 -1 O LYS D 173 N SER D 150 SHEET 3 AB2 4 TYR D 206 THR D 213 -1 O LEU D 208 N VAL D 172 SHEET 4 AB2 4 VAL D 193 THR D 195 -1 N HIS D 194 O VAL D 211 SHEET 1 AB3 4 SER D 150 LEU D 154 0 SHEET 2 AB3 4 ALA D 167 TYR D 175 -1 O LYS D 173 N SER D 150 SHEET 3 AB3 4 TYR D 206 THR D 213 -1 O LEU D 208 N VAL D 172 SHEET 4 AB3 4 VAL D 199 LEU D 200 -1 N VAL D 199 O SER D 207 SHEET 1 AB4 3 THR D 181 TRP D 184 0 SHEET 2 AB4 3 TYR D 224 HIS D 230 -1 O ASN D 227 N SER D 183 SHEET 3 AB4 3 THR D 235 VAL D 241 -1 O LYS D 239 N CYS D 226 SHEET 1 AB5 4 LEU E 24 THR E 25 0 SHEET 2 AB5 4 VAL E 38 GLY E 44 -1 O THR E 43 N THR E 25 SHEET 3 AB5 4 THR E 92 ILE E 97 -1 O LEU E 95 N ILE E 40 SHEET 4 AB5 4 PHE E 84 SER E 89 -1 N SER E 89 O THR E 92 SHEET 1 AB6 5 SER E 29 GLY E 32 0 SHEET 2 AB6 5 THR E 126 VAL E 130 1 O LYS E 127 N VAL E 30 SHEET 3 AB6 5 ALA E 106 SER E 112 -1 N TYR E 108 O THR E 126 SHEET 4 AB6 5 VAL E 55 GLN E 60 -1 N TYR E 58 O TYR E 109 SHEET 5 AB6 5 LYS E 67 ILE E 70 -1 O MET E 69 N TRP E 57 SHEET 1 AB7 4 SER E 29 GLY E 32 0 SHEET 2 AB7 4 THR E 126 VAL E 130 1 O LYS E 127 N VAL E 30 SHEET 3 AB7 4 ALA E 106 SER E 112 -1 N TYR E 108 O THR E 126 SHEET 4 AB7 4 VAL E 121 PHE E 122 -1 O VAL E 121 N SER E 112 SHEET 1 AB8 4 SER E 142 PHE E 146 0 SHEET 2 AB8 4 ALA E 158 PHE E 167 -1 O LEU E 163 N THR E 144 SHEET 3 AB8 4 TYR E 200 LEU E 208 -1 O TYR E 200 N PHE E 167 SHEET 4 AB8 4 VAL E 187 THR E 189 -1 N GLU E 188 O TYR E 205 SHEET 1 AB9 4 SER E 142 PHE E 146 0 SHEET 2 AB9 4 ALA E 158 PHE E 167 -1 O LEU E 163 N THR E 144 SHEET 3 AB9 4 TYR E 200 LEU E 208 -1 O TYR E 200 N PHE E 167 SHEET 4 AB9 4 SER E 193 LYS E 194 -1 N SER E 193 O ALA E 201 SHEET 1 AC1 4 SER E 181 VAL E 183 0 SHEET 2 AC1 4 VAL E 172 ALA E 178 -1 N ALA E 178 O SER E 181 SHEET 3 AC1 4 TYR E 219 HIS E 225 -1 O GLN E 222 N ALA E 175 SHEET 4 AC1 4 SER E 228 VAL E 234 -1 O SER E 228 N HIS E 225 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.05 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03 SSBOND 3 CYS B 45 CYS B 100 1555 1555 2.01 SSBOND 4 CYS D 41 CYS D 118 1555 1555 2.03 SSBOND 5 CYS D 170 CYS D 226 1555 1555 2.03 SSBOND 6 CYS E 42 CYS E 110 1555 1555 2.02 SSBOND 7 CYS E 162 CYS E 221 1555 1555 2.04 LINK SG CYS C 12 C25 MOV D 301 1555 1555 1.77 CISPEP 1 TYR A 209 PRO A 210 0 2.45 CISPEP 2 HIS B 51 PRO B 52 0 2.94 CISPEP 3 PHE D 176 PRO D 177 0 -7.39 CISPEP 4 TYR E 168 PRO E 169 0 7.88 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000